Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-06-009111
Filing Date
2006-09-27
Accepted
2006-09-27 15:45:00
Documents
7
Period of Report
2006-06-30

Document Format Files

Seq Description Document Type Size
1 VIRAGEN INC. g03498e10vk.htm 10-K 1069111
2 EX-21.1 SUBSIDIARIES OF THE COMPANY g03498exv21w1.htm EX-21.1 4349
3 EX-23.1 CONSENT OF ERNST & YOUNG LLP g03498exv23w1.htm EX-23.1 2557
4 EX-31.1 SECTION 302 CHIEF EXECUTIVE OFFICER CERTIFICATION g03498exv31w1.htm EX-31.1 6628
5 EX-31.2 SECTION 302 CHIEF FINANCIAL OFFICER CERTIFICATION g03498exv31w2.htm EX-31.2 6629
6 EX-32.1 SECTION 906 CHIEF EXECUTIVE OFFICER CERTIFICATION g03498exv32w1.htm EX-32.1 3707
7 EX-32.2 SECTION 906 CHIEF FINANCIAL OFFICER CERTIFICATION g03498exv32w2.htm EX-32.2 3716
  Complete submission text file 0000950144-06-009111.txt   1098135
Mailing Address 865 SW 78TH AVENUE SUITE 100 PLANTATION FL 33324
Business Address 865 SW 78TH AVENUE SUITE 100 PLANTATION FL 33324 9542338746
VIRAGEN INC (Filer) CIK: 0000353482 (see all company filings)

EIN.: 592101668 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-15823 | Film No.: 061111204
SIC: 2836 Biological Products, (No Diagnostic Substances)